4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-034164
President and CEO sold 18,756 shares at an average $17.50 ($328,260)
- President and CEO acquired 18,756 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2017-08-31 | Option exercise | +18,756 | $0.95 | $17,724 | 23,001 | D |
| McCarthy Sean A. President and CEO | 2017-08-31 | Sale | −15,756 | $17.50 | $275,730 | 7,245 | D |
| McCarthy Sean A. President and CEO | 2017-08-31 | Sale | −3,000 | $17.51 | $52,530 | 4,245 | D |
| Derivatives | |||||||
| McCarthy Sean A. President and CEO | 2017-08-31 | Option exercise · Stock Option (right to buy) | −18,756 | 34,973 | D | ||
| Open-market sales · 18,756 sh · avg $17.50 · $328,260 | |||||||
Loading xslF345X03/doc1.xml…